EPO sees record patenting levels, but national fortunes are mixed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO sees record patenting levels, but national fortunes are mixed

The world might be reeling from recession but it seems as if companies are innovating ­ – or at least patenting – their way out of it. Filings at the EPO were up 5.7% last year, with China recording growth of 11.3%

Only one country in the list of top 10 national filers saw a decline in its number of filings: applications from Italy were down 4%.

Applications from the US, South Korea, Japan and Switzerland all grew by more than 5% on 2011, according to figures released today by the EPO.

China now accounts for 7.3% of applications at the EPO. The picture for its fellow BRIC countries is mixed: applications from Brazil rose by 7.1%, while applications from Russia and India fell (7.7% and 8.7% respectively).

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article